Simvastatin as an Add-on Treatment to Interferon-beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis

Clinical trial NCT00492765 · COMPLETED

Trial details

NCT number: NCT00492765
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2006-02-01
Primary completion: 2010-04-01
Enrollment: 380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.